View printer-friendly version << Back
MEDNAX Appoints Stephen D. Farber as Executive Vice President, to Succeed Chief Financial Officer

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Aug. 23, 2018-- MEDNAX, Inc. (NYSE: MD) (the “Company”), today announced the appointment of Stephen D. Farber as Executive Vice President, effective August 27, 2018. The Company anticipates that Mr. Farber will assume the additional role of Chief Financial Officer in November 2018, following the Company’s release of its operating results for the period ending September 30, 2018, to succeed Vivian Lopez-Blanco, who recently announced her planned retirement from the Company.

“We are very pleased to have Stephen join our team at MEDNAX,” said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. “His unique background as a proven leader of multiple large healthcare enterprises makes him an outstanding addition to our Company. Stephen’s depth of knowledge and broad experience will serve us and our shareholders well as we continue the execution of our operating and strategic plans and remain committed to our mission of taking great care of our patients.”

Mr. Farber has 25 years of healthcare experience, including as a senior leader and Chief Financial Officer of large, publicly-traded and private healthcare enterprises. He most recently was Executive Vice President and Chief Financial Officer of Kindred Healthcare, Inc., which was one of the nation’s largest providers of post-acute services with approximately $6 billion in revenue and 85,000 employees, until its sale in July 2018. Earlier in his career, Mr. Farber served as Chief Financial Officer of Tenet Healthcare Corporation (NYSE: THC), which during his tenure was the nation’s second-largest investor-owned healthcare services company.

Mr. Farber has extensive experience in corporate, operational and financial strategy, and has successfully helped grow and transform healthcare companies. In addition to his executive roles at Kindred and Tenet, he has been involved in various private equity efforts, including as a healthcare executive-in-residence with Warburg Pincus LLC, a global investment firm with more than $45 billion under management. Mr. Farber began his career as an investment banker with J.P. Morgan and Donaldson, Lufkin & Jenrette, where he focused on healthcare mergers and acquisitions and leveraged finance.


MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of approximately 4,100 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a management services company and a consulting services company. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to MEDNAX’s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations